Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)

被引:0
作者
Veronica F. Colomer Gould
机构
[1] Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional,
[2] Departamento de Fisiología,undefined
[3] Biofísica,undefined
[4] y Neurociencias,undefined
来源
Neurotherapeutics | 2012年 / 9卷
关键词
Mouse; transgenic; Machado-Joseph; spinocerebellar ataxia type 3; SCA3; MJD.;
D O I
暂无
中图分类号
学科分类号
摘要
Machado-Joseph disease, also called spinocerebellar ataxia type 3 (MJD/SCA3), is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a pathological polyglutamine stretch (mutant ataxin-3). Seven transgenic mouse models expressing full-length human mutant ataxin-3 throughout the brain have been generated and are compared in this review. They vary in the corresponding transgenic DNA constructs with differences that include the encoded human ataxin-3 isoform(s), number of polyglutamine(s), and the promoter driving transgene expression. The behaviors/signs evaluated in most models are body weight, balance/coordination, locomotor activity, gait, limb position, and age at death. The pathology analyzed includes presence of neuronal intranuclear inclusions, and qualitative evidence of neurodegeneration. On the basis of striking similarities in age-range of detection and number of behavior/sign abnormalities and pathology, all but 1 mouse model could be readily sorted into groups with high, intermediate, and low severity of phenotype. Stereological analysis of neurodegeneration was performed in the same brain regions in 2 mouse models; the corresponding results are consistent with the classification of the mouse models.
引用
收藏
页码:285 / 296
页数:11
相关论文
共 164 条
[1]  
Nakano KK(1972)Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts Neurology 22 49-55
[2]  
Dawson DM(1972)Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity J Neurol Sci 17 149-166
[3]  
Spence A(1976)Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder Neurology 26 703-714
[4]  
Woods BT(1977)Azorean disease of the nervous system N Engl J Med 296 1505-1508
[5]  
Schaumburg HH(1978)Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions Neurology 28 703-709
[6]  
Rosenberg RN(1978)Joseph’s disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands Adv Neurol 21 33-57
[7]  
Nyhan WL(1980)Presumably Azorean disease in a presumably non-Portuguese family Neurology 30 1084-1089
[8]  
Bay C(1980)Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family Neurology 30 319-322
[9]  
Shore P(1984)The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases Can J Neurol Sci 11 510-525
[10]  
Romanul FC(1984)Machado-Joseph-Azorean disease. A ten-year study Arch Neurol 41 921-925